152 related articles for article (PubMed ID: 22739228)
1. Idiopathic membranous nephropathy: clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center.
Sprangers B; Bomback AS; Cohen SD; Radhakrishnan J; Valeri A; Markowitz GS; D'Agati V; Appel GB
Am J Nephrol; 2012; 36(1):78-89. PubMed ID: 22739228
[TBL] [Abstract][Full Text] [Related]
2. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
3. Low glomerular density is a risk factor for progression in idiopathic membranous nephropathy.
Tsuboi N; Kawamura T; Miyazaki Y; Utsunomiya Y; Hosoya T
Nephrol Dial Transplant; 2011 Nov; 26(11):3555-60. PubMed ID: 21771759
[TBL] [Abstract][Full Text] [Related]
4. Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.
Terrier B; Delmas Y; Hummel A; Presne C; Glowacki F; Knebelmann B; Combe C; Lesavre P; Maillard N; Noël LH; Patey-Mariaud de Serre N; Nusbaum S; Radford I; Buzyn A; Fakhouri F
Nephrol Dial Transplant; 2007 May; 22(5):1369-76. PubMed ID: 17255123
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy.
McQuarrie EP; Stirling CM; Geddes CC
Nephrol Dial Transplant; 2012 Jan; 27(1):235-42. PubMed ID: 21558430
[TBL] [Abstract][Full Text] [Related]
7. Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy?
Ponticelli C; Passerini P
J Nephrol; 2010; 23(2):156-63. PubMed ID: 20213607
[TBL] [Abstract][Full Text] [Related]
8. [The late results of treating membranous glomerulonephritis].
Belovezhdov N; Robeva R; Dimitrova V
Vutr Boles; 1990; 29(3):53-60. PubMed ID: 2284800
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.
Polanco N; Gutiérrez E; Rivera F; Castellanos I; Baltar J; Lorenzo D; Praga M;
Nephrol Dial Transplant; 2012 Jan; 27(1):231-4. PubMed ID: 21624942
[TBL] [Abstract][Full Text] [Related]
10. Recent advances and prognosis in idiopathic membranous nephropathy.
Segal PE; Choi MJ
Adv Chronic Kidney Dis; 2012 Mar; 19(2):114-9. PubMed ID: 22449349
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
[TBL] [Abstract][Full Text] [Related]
12. [Immunosuppressive therapy for idiopathic membranous glomerulopathy].
Branten AJ; Wetzels JF
Ned Tijdschr Geneeskd; 1998 Apr; 142(14):767-72. PubMed ID: 9646608
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
14. An overview of immunosuppressive therapy in idiopathic membranous nephropathy.
Maas R; Hofstra JM; Wetzels JF
Minerva Med; 2012 Aug; 103(4):253-66. PubMed ID: 22805618
[TBL] [Abstract][Full Text] [Related]
15. Membranous nephropathy in systemic lupus erythematosus: long-term outcome and prognostic factors of 103 patients.
Moroni G; Quaglini S; Gravellone L; Gallelli B; Leoni A; Messa P; Sinico RA
Semin Arthritis Rheum; 2012 Apr; 41(5):642-51. PubMed ID: 22285127
[TBL] [Abstract][Full Text] [Related]
16. Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy.
Laluck BJ; Cattran DC
Am J Kidney Dis; 1999 Jun; 33(6):1026-32. PubMed ID: 10352189
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic membranous nephropathy: diagnosis and treatment.
Fervenza FC; Sethi S; Specks U
Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of untreated patients with idiopathic membranous nephropathy.
Schieppati A; Mosconi L; Perna A; Mecca G; Bertani T; Garattini S; Remuzzi G
N Engl J Med; 1993 Jul; 329(2):85-9. PubMed ID: 8510707
[TBL] [Abstract][Full Text] [Related]
19. IgM nephropathy: clinical picture and long-term prognosis.
Myllymäki J; Saha H; Mustonen J; Helin H; Pasternack A
Am J Kidney Dis; 2003 Feb; 41(2):343-50. PubMed ID: 12552495
[TBL] [Abstract][Full Text] [Related]
20. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]